Cell Therapeutics Inc (NASDAQ:CTIC)

CAPS Rating: 1 out of 5

The Company develops, acquires and commercializes novel treatments for cancer and focuses its research and in-licensing activities on identifying and developing new, less toxic and effective ways to treat cancer.

Recs

1
Player Avatar SnarkyApple (55.00) Submitted: 9/12/2012 4:20:34 PM : Underperform Start Price: $3.45 CTIC Score: +62.16

Obvious example of stock market manipulation. CTIC is worthless.

Member Avatar GenFrogKing7 (90.79) Submitted: 9/24/2012 12:57:07 PM
Recs: 0

Good call :)

Featured Broker Partners


Advertisement